Tip: You can further refine your news selection by topics, departments, countries and industries.
First immunotherapy for rare and aggressive skin cancer in the European Union approved Initial launches planned in Germany and the UK 22-Sep-2017 - Merck and Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for BAVENCIO® (avelumab) as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (mMCC), a rare and aggressive skin cancer. BAVENCIO will have marketing ... avelumab cancer drugs immunotherapies +3 Loading...
EU project to find vaccine against ticks 09-Sep-2013 - European Union-funded researchers are launching a five-year project to find a vaccine against ticks to prevent them transmitting the diseases they carry to people they bite. The €3 million project is funded under the Seventh Framework Programme for Research and Technological Development (FP7). ... babesiosis encephalitis Lyme disease +1 Loading...
European Commission authorizes EU-wide marketing and distribution of Biofrontera's Ameluz 20-Dec-2011 - Biofrontera was informed by the European Commission that its product Ameluz® (in development called BF-200 ALA) was approved for distribution throughout the entire EU, Norway, Island and Liechtenstein. Already in October had the responsible "European Medicines Agency" recommended the approval ... actinic keratosis photo-dynamic therapies Loading...
Takeda’s Edarbi receives European marketing authorisation for the treatment of essential hypertension 12-Dec-2011 - Takeda Pharmaceutical Company Limited announced that the European Commission has granted marketing authorisation for Edarbi® (azilsartan medoxomil), a new once-daily angiotensin receptor blocker (ARB) (also known as angiotensin II receptor antagonist [AIIRA]) for the treatment of essential ... cardiovascular diseases hypertension phase III studies Loading...
Cellzome Founder wins EU Women Innovators Award Dr. Gitte Neubauer awarded first prize for the foundation of Cellzome 08-Dec-2011 - Cellzome announced that Dr. Gitte Neubauer, one of the scientific founders of Cellzome, has received the highly esteemed EU Women Innovators Award. The award recognizes her outstanding contribution in translating academic research into a commercial venture through the foundation of Cellzome. The ... Loading...
EuropaBio welcomes the European Commission’s initiative to develop a Resource Efficiency Roadmap for Europe EuropaBio recalls the vital role played by biotechnology and calls for strong EU commitment to realise the full potential of a bio-based economy 27-Sep-2011 - Europe needs more tangible and sound policies on resource efficiency in the short and medium term to meet its objective of becoming a smart, sustainable and inclusive economy. The launch of the European Commission’s Roadmap for Resource Efficiency represents a step towards this goal. However, to ... agriculture biotechnology green biotechnology Loading...
S*BIO’s JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission for the Treatment of Myelofibrosis 20-Oct-2010 - S*BIO Pte Ltd announced that the European Commission (EC)has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for thetreatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and postessentialthrombocythemia myelofibrosis ... diseases food inhibitors +4 Loading...
Novartis receives approval in the European Union for Menveo 22-Mar-2010 - Novartis announced that the European Commission (EC) granted a Marketing Authorization for Menveo® (Meningococcal Group A, C, W135 and Y conjugate vaccine) in all 27 European member states. Menveo is indicated for the active immunization of adolescents (from 11 years of age) and adults at risk of ... bacteria bacterial meningitis clinical trials +5 Loading...
The European Commission grants Orphan Drug Designation for Intravenous CP-4126 for the Treatment of Pancreatic Cancer 03-Nov-2009 - Clavis Pharma ASA announced that the European Commission has granted Orphan Drug Designation (Orphan Medicinal Product) for Intravenous CP-4126 for the treatment of pancreatic cancer. The designation follows the recommendation given by the European Medicines Agency (EMEA) in September this ... Expression food Orphan Drug Designation +3 Loading...
Movetis obtains EU authorisation for the commercialisation of Resolor (prucalopride) 26-Oct-2009 - Movetis announced that it has obtained approval from the European Commission for the commercialisation of its lead product Resolor (prucalopride – a 1mg and 2mg once a day oral tablet) for the symptomatic treatment of chronic constipation (CC) in women in whom laxatives fail to provide adequate ... chronic constipation clinical trials Iceland +2 Loading...
Search all news
News from Europäische Kommission by topic
Biotechnology Food Agriculture Orphan drugs Vaccines
See Also
(PDF) The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML - DOKUMEN.TIPSJournal of Hematology & OncologyNews by Europäische Kommission pharma => bionity.comNetzwerk von Richard A. Leach, Analyse der 36-Beziehungen First immunotherapy for rare and aggressive skin cancer in the European Union approved Initial launches planned in Germany and the UK View news
EU project to find vaccine against ticks View news
European Commission authorizes EU-wide marketing and distribution of Biofrontera's Ameluz View news
Takeda’s Edarbi receives European marketing authorisation for the treatment of essential hypertension View news
Cellzome Founder wins EU Women Innovators Award Dr. Gitte Neubauer awarded first prize for the foundation of Cellzome View news
EuropaBio welcomes the European Commission’s initiative to develop a Resource Efficiency Roadmap for Europe EuropaBio recalls the vital role played by biotechnology and calls for strong EU commitment to realise the full potential of a bio-based economy View news
S*BIO’s JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission for the Treatment of Myelofibrosis View news
Novartis receives approval in the European Union for Menveo View news
The European Commission grants Orphan Drug Designation for Intravenous CP-4126 for the Treatment of Pancreatic Cancer View news
Movetis obtains EU authorisation for the commercialisation of Resolor (prucalopride) View news
All news on biotechnology
Loading...
News from Europäische Kommission by department
First immunotherapy for rare and aggressive skin cancer in the European Union approved Initial launches planned in Germany and the UK View news
European Commission authorizes EU-wide marketing and distribution of Biofrontera's Ameluz View news
Takeda’s Edarbi receives European marketing authorisation for the treatment of essential hypertension View news
S*BIO’s JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission for the Treatment of Myelofibrosis View news
Novartis receives approval in the European Union for Menveo View news
The European Commission grants Orphan Drug Designation for Intravenous CP-4126 for the Treatment of Pancreatic Cancer View news
Movetis obtains EU authorisation for the commercialisation of Resolor (prucalopride) View news
European Commission Approves Genzyme’s Mozobil Product Provides Significant New Option for Certain Cancer Patients Requiring a Stem Cell Transplant View news
European Commission approves Samsca for Hyponatraemia View news
New test eliminates need for skin irritancy tests on rabbits View news
All news from research and development
Loading...
News from Europäische Kommission by industry
First immunotherapy for rare and aggressive skin cancer in the European Union approved Initial launches planned in Germany and the UK View news
EU project to find vaccine against ticks View news
European Commission authorizes EU-wide marketing and distribution of Biofrontera's Ameluz View news
Takeda’s Edarbi receives European marketing authorisation for the treatment of essential hypertension View news
S*BIO’s JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission for the Treatment of Myelofibrosis View news
Novartis receives approval in the European Union for Menveo View news
The European Commission grants Orphan Drug Designation for Intravenous CP-4126 for the Treatment of Pancreatic Cancer View news
Movetis obtains EU authorisation for the commercialisation of Resolor (prucalopride) View news
European Commission Approves Genzyme’s Mozobil Product Provides Significant New Option for Certain Cancer Patients Requiring a Stem Cell Transplant View news
European Commission approves Samsca for Hyponatraemia View news
All news for Pharma
Loading...
News from Europäische Kommission by country
Cellzome Founder wins EU Women Innovators Award Dr. Gitte Neubauer awarded first prize for the foundation of Cellzome view news
EuropaBio welcomes the European Commission’s initiative to develop a Resource Efficiency Roadmap for Europe EuropaBio recalls the vital role played by biotechnology and calls for strong EU commitment to realise the full potential of a bio-based economy view news
Movetis obtains EU authorisation for the commercialisation of Resolor (prucalopride) view news
Loading...
Haven't found the right news yet?
The bionity.com news search
Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,002 life science news from business and science, which you can search by topic and organization, filtered by time and geography.
Start news search now
